| Epidaza (chidamide) / Chipscreen |
| Recruiting | 2 | 74 | RoW | chidamide and toripalimab | Sun Yat-sen University | Sarcoma | 12/23 | 12/24 | | |
ChiCTR2200065746: Clinical study of chidamide combined with tislelizumab in the treatment of advanced osteosarcoma |
|
|
| Not yet recruiting | 2 | 23 | China | chidamide combined with tislelizumab | Beijing Jishuitan Hospital ; Beijing Jishuitan Hospital, self-funded | osteosarcoma | | | | |
NCT06125171: Tucidinostat Plus Apatinib for Advanced Osteosarcoma |
|
|
| Not yet recruiting | 2 | 46 | NA | Tucidinostat, Apatinib | Wuhan Union Hospital, China | Osteosarcoma | 12/24 | 12/25 | | |
ChiCTR2100048715: Clinical trial of Chidamide in combination with Anlotinib for refractory and advanced soft tissue sarcoma after failure of standard therapy |
|
|
| Not yet recruiting | N/A | 56 | | Treatment was performed according to the combination regimen of cidabentamine and amlotinib | Shanghai Sixth People's Hospital; Shanghai Sixth People's Hospital, Shanghai Sixth People's Hospital | soft tissue sarcoma | | | | |
